Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for National Research (NRC) over the last 16 years, with Q3 2025 value amounting to $1.5 million.

  • National Research's Change in Accured Expenses rose 87880.79% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $588000.0, marking a year-over-year increase of 1783.57%. This contributed to the annual value of $202000.0 for FY2024, which is 12630.21% up from last year.
  • National Research's Change in Accured Expenses amounted to $1.5 million in Q3 2025, which was up 87880.79% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, National Research's Change in Accured Expenses ranged from a high of $2.5 million in Q1 2024 and a low of -$3.1 million during Q4 2022
  • Moreover, its 5-year median value for Change in Accured Expenses was -$83000.0 (2021), whereas its average is -$86947.4.
  • In the last 5 years, National Research's Change in Accured Expenses crashed by 360361.45% in 2022 and then skyrocketed by 265876.29% in 2024.
  • Quarter analysis of 5 years shows National Research's Change in Accured Expenses stood at -$83000.0 in 2021, then tumbled by 3603.61% to -$3.1 million in 2022, then surged by 58.98% to -$1.3 million in 2023, then dropped by 23.55% to -$1.6 million in 2024, then skyrocketed by 194.87% to $1.5 million in 2025.
  • Its Change in Accured Expenses stands at $1.5 million for Q3 2025, versus $1.1 million for Q2 2025 and -$472000.0 for Q1 2025.